Dignitana AB Publishes Q4 2021 Interim Report
Continued US growth fuels 25 percent revenue increase Financial highlights Q4 2021 · Net sales amounted to 16.2 MSEK (12.9), an increase of 25 percent over the same period 2020. · Operating result amounted to -11.4 MSEK (-19.7). · Net result after financial items amounted to -11.8 MSEK (-20.8). · Earnings per share were -0,18 SEK (-0,37). · Cash Balance amounted to 14.5 MSEK (78.8). · Average Daily Treatment Revenue (ADTR)* was 155 TSEK (130), an increase of 19 percent over the same period in 2020. Financial highlights January – December 2021 · Net sales